G
Guggenheim Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
201 |
201
Universal Health Services
UHS
$12.1B
|
JC
Jason Cassorla
| $190.12 | $208 |
9%
upside
| Buy | 5 months ago |
|
202 |
202
Humana
HUM
$37B
|
JC
Jason Cassorla
| $307.92 | $326 |
6%
upside
| Buy | 5 months ago |
|
203 |
203
Veracyte
VCYT
$2.55B
|
SN
Subbu Nambi
| $32.43 | $37 |
14%
upside
| Buy | 5 months ago |
|
204 |
204
FirstEnergy
FE
$25.1B
|
SP
Shahriar Pourreza
| $43.48 | $47 |
8%
upside
| Buy | 5 months ago |
|
205 |
NBTX
205
Nanobiotix
NBTX
$419M
|
MS
Michael Schmidt
| $8.70 | $8 |
8%
downside
| Buy | 5 months ago |
|
206 |
206
Sportradar
SRAD
$9.14B
|
CB
Curry Baker
| $30.87 | $27 |
13%
downside
| Buy | 5 months ago |
|
207 |
207
Netflix
NFLX
$529B
|
MM
Michael Morris
| $1,243.82 | $1,100 |
12%
downside
| Buy | 5 months ago |
|
208 |
MAZE
208
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
|
DC
Debjit Chattopadhyay
| $15.88 | $19 |
20%
upside
| Buy | 5 months ago |
|
209 |
209
Progress Software
PRGS
$1.88B
|
JD
John Difucci
| $43.56 | $83 |
91%
upside
| Buy | 5 months ago |
|
210 |
210
Spire
SR
$4.46B
|
SP
Shahriar Pourreza
| $75.54 | $72 |
5%
downside
| Neutral | 5 months ago |
|
211 |
211
Merus
MRUS
$5.1B
|
MS
Michael Schmidt
| $67.47 | $109 |
62%
upside
| Buy | 5 months ago |
|
212 |
CNTA
212
Centessa Pharmaceuticals
CNTA
$2.11B
|
DC
Debjit Chattopadhyay
| $15.73 | $28 |
78%
upside
| Buy | 5 months ago |
|
213 |
VALN
213
Valneva
VALN
$743M
|
DF
Dana Flanders
| $8.65 | $15 |
73%
upside
| Buy | 5 months ago |
|
214 |
214
Verastem
VSTM
$663M
|
MS
Michael Schmidt
| $10.77 | $14 |
30%
upside
| Buy | 5 months ago |
|
215 |
215
Darden Restaurants
DRI
$24.5B
|
GF
Greg Francfort
| $210.14 | $220 |
5%
upside
| Buy | 5 months ago |
|
216 |
216
DTE Energy
DTE
$28.4B
|
SP
Shahriar Pourreza
| $136.60 | $147 |
8%
upside
| Buy | 5 months ago |
|
217 |
217
NextEra Energy, Inc.
NEE
$146B
|
SP
Shahriar Pourreza
| $70.90 | $89 |
26%
upside
| Buy | 5 months ago |
|
218 |
218
Absci
ABSI
$368M
|
VD
Vamil Divan
| $2.46 | $10 |
307%
upside
| Buy | 5 months ago |
|
219 |
219
Incyte
INCY
$16.9B
|
MS
Michael Schmidt
| $86.64 | $92 |
6%
upside
| Neutral | 5 months ago |
|
220 |
220
Zevra Therapeutics
ZVRA
$502M
|
EH
Eddie Hickman
| $8.95 | $22 |
146%
upside
| Buy | 5 months ago |
|
221 |
221
GH Research
GHRS
$874M
|
EH
Eddie Hickman
| $14.09 | $32 |
127%
upside
| Buy | 5 months ago |
|
222 |
222
Vaxcyte
PCVX
$4.29B
|
SF
Seamus Fernandez
| $33.02 | $160 |
385%
upside
| Buy | 5 months ago |
|
223 |
223
Dianthus Therapeutics
DNTH
$853M
|
YS
Yatin Suneja
| $26.50 | $84 |
217%
upside
| Buy | 5 months ago |
|
224 |
ZBIO
224
Zenas BioPharma, Inc. Common Stock
ZBIO
$864M
|
YS
Yatin Suneja
| $20.51 | $45 |
119%
upside
| Buy | 5 months ago |
|
225 |
VG
225
Venture Global, Inc.
VG
$31.2B
|
SP
Shahriar Pourreza
| $12.84 | $20 |
56%
upside
| Buy | 6 months ago |
|